175 related articles for article (PubMed ID: 31759623)
1. Defining the role of adjuvant therapy for early-stage large cell neuroendocrine carcinoma.
Wakeam E; Adibfar A; Stokes S; Leighl NB; Giuliani ME; Varghese TK; Darling GE
J Thorac Cardiovasc Surg; 2020 May; 159(5):2043-2054.e9. PubMed ID: 31759623
[TBL] [Abstract][Full Text] [Related]
2. The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung.
Kujtan L; Muthukumar V; Kennedy KF; Davis JR; Masood A; Subramanian J
J Thorac Oncol; 2018 May; 13(5):707-714. PubMed ID: 29391287
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis.
Raman V; Jawitz OK; Yang CJ; Tong BC; D'Amico TA; Berry MF; Harpole DH
Ann Thorac Surg; 2019 Aug; 108(2):377-383. PubMed ID: 31004586
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database.
Filosso PL; Guerrera F; Evangelista A; Galassi C; Welter S; Rendina EA; Travis W; Lim E; Sarkaria I; Thomas PA;
Eur J Cardiothorac Surg; 2017 Aug; 52(2):339-345. PubMed ID: 28459956
[TBL] [Abstract][Full Text] [Related]
5. Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.
Wakeam E; Acuna SA; Leighl NB; Giuliani ME; Finlayson SRG; Varghese TK; Darling GE
Lung Cancer; 2017 Jul; 109():78-88. PubMed ID: 28577955
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Chemotherapy Improves Survival in pN-positive Clinical Stage IIIA Non-Small Cell Lung Cancer After Neoadjuvant Therapy and Resection.
Atay SM; Amini M; Ding L; David EA; Mcfadden PM; Wightman SC; Kim AW
Ann Thorac Surg; 2021 Jul; 112(1):197-205. PubMed ID: 33121965
[TBL] [Abstract][Full Text] [Related]
7. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
[TBL] [Abstract][Full Text] [Related]
8. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
[TBL] [Abstract][Full Text] [Related]
9. Enhanced efficacy of adjuvant chemotherapy and radiotherapy in selected cases of surgically resected neuroendocrine carcinoma of the uterine cervix: A retrospective cohort study.
Xie S; Song L; Yang F; Tang C; Yang S; He J; Pan X
Medicine (Baltimore); 2017 Mar; 96(11):e6361. PubMed ID: 28296773
[TBL] [Abstract][Full Text] [Related]
10. Indications for Adjuvant Mediastinal Radiotherapy in Surgically Resected Small Cell Lung Cancer.
Wakeam E; Giuliani M; Leighl NB; Finlayson SRG; Varghese TK; Darling GE
Ann Thorac Surg; 2017 May; 103(5):1647-1653. PubMed ID: 28267977
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Chemotherapy After Lobectomy for T1-2N0 Non-Small Cell Lung Cancer: Are the Guidelines Supported?
Speicher PJ; Gu L; Wang X; Hartwig MG; D'Amico TA; Berry MF
J Natl Compr Canc Netw; 2015 Jun; 13(6):755-61. PubMed ID: 26085391
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis.
Foster CC; Rusthoven CG; Sher DJ; Feldman L; Pasquinelli M; Spiotto MT; Koshy M
Lung Cancer; 2019 Apr; 130():162-168. PubMed ID: 30885339
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy, extent of resection, and immunoistochemical neuroendocrine markers as prognostic factors of early-stage large-cell neuroendocrine carcinoma.
Andreetti C; Ibrahim M; Gagliardi A; Poggi C; Maurizi G; Armillotta D; Peritone V; Teodonio L; Rendina EA; Venuta F; Anile M; Natale G; Santini M; Fiorelli A
Thorac Cancer; 2022 Apr; 13(7):900-912. PubMed ID: 35170859
[TBL] [Abstract][Full Text] [Related]
14. Sublobar resection is associated with decreased survival for patients with early stage large-cell neuroendocrine carcinoma of the lung.
Lutfi W; Schuchert MJ; Dhupar R; Sarkaria I; Christie NA; Yang CJ; Deng JZ; Luketich JD; Okusanya OT
Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):517-524. PubMed ID: 31177277
[TBL] [Abstract][Full Text] [Related]
15. Role of Immunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung.
Komiya T; Ravindra N; Powell E
Asian Pac J Cancer Prev; 2021 Feb; 22(2):365-370. PubMed ID: 33639649
[TBL] [Abstract][Full Text] [Related]
16. Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis.
Brandt WS; Yan W; Zhou J; Tan KS; Montecalvo J; Park BJ; Adusumilli PS; Huang J; Bott MJ; Rusch VW; Molena D; Travis WD; Kris MG; Chaft JE; Jones DR
J Thorac Cardiovasc Surg; 2019 Feb; 157(2):743-753.e3. PubMed ID: 30415902
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant Chemotherapy Versus Observation Following Resection for Patients With Nonmetastatic Poorly Differentiated Colorectal Neuroendocrine Carcinomas.
Mao R; Li K; Cai JQ; Luo S; Turner M; Blazer D; Zhao H
Ann Surg; 2021 Aug; 274(2):e126-e133. PubMed ID: 31478977
[TBL] [Abstract][Full Text] [Related]
18. The role of postoperative radiotherapy (PORT) in pulmonary large cell neuroendocrine carcinoma (PLCNEC).
Gang Jin ; Lili Xue ; Xiang Song
Cancer Radiother; 2020 Jun; 24(3):215-221. PubMed ID: 32156456
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study.
Cattrini C; Cerbone L; Rubagotti A; Zinoli L; Latocca MM; Messina C; Zanardi E; Boccardo F
Clin Genitourin Cancer; 2019 Aug; 17(4):e724-e732. PubMed ID: 31160193
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis.
Ecker BL; McMillan MT; Datta J; Mamtani R; Giantonio BJ; Dempsey DT; Fraker DL; Drebin JA; Karakousis GC; Roses RE
Cancer; 2016 Mar; 122(5):693-701. PubMed ID: 26717303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
